Clinical Trial Update: A Phase II Trial of Valproic Acid in Patients With Advanced Thyroid Cancers of Follicular Cell Origin [Phase 2]

View source ↗

Summary

Phase II trial evaluating valproic acid in patients with advanced thyroid cancers of follicular cell origin completed; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Follicular Thyroid Carcinoma

Drugs mentioned

• VALPROIC ACID (Valproic acid)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Thyroid Neoplasm | Phase 2 | Status: COMPLETED | Results posted: 2016-12-14